A comparison of the effects of the GLP-1 analogue liraglutide and insulin glargine on endothelial function and metabolic parameters: A randomized, controlled trial sapporo athero-incretin study 2 (SAIS2)

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Nomoto, Hiroshi ^a   Miyoshi, Hideaki ^a   Furumoto, Tomoo ^a,b   Oba, Koji ^c,d   Tsutsui, Hiroyuki ^a   Miyoshi, Arina ^a   Kondo, Takuma ^a   Tsuchida, Kenichi ^e   Atsumi, Tatsuya ^a   Manda, Naoki ^e   Kurihara, Yoshio ^f   Aoki, Shin ^g  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sapporo Medical Center   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e Manda Memorial Hospital   (Japan)

^f Kurihara Diabetic Care Clinic   (Japan)

^g Aoki Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN A1C; INSULIN GLARGINE; LIRAGLUTIDE; REACTIVE OXYGEN METABOLITE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; AUGMENTATION INDEX; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; GLUCOSE METABOLISM; HEART INDEX; HEMOGLOBIN BLOOD LEVEL; HUMAN; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; ATHEROSCLEROSIS; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; ENDOTHELIUM; FEMALE; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADULT; AGED; ATHEROSCLEROSIS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN GLARGINE; LIRAGLUTIDE; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84942673427     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135854     Document Type: Article

References (44)

1. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010; 375(9733):2215-22. Epub 2010/07/09. doi: 10.1016/s0140-6736(10) 60484-9 PMID: 20609967; PubMed Central PMCID: PMC2904878.
2. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. The New England journal of medicine. 1998; 339(4):229-34. Epub 1998/07/23. doi: 10.1056/ nejm199807233390404 PMID: 9673301.
3. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation. 1993; 88(3):837-45. Epub 1993/09/01. PMID: 8353913.
4. Kimura K, Minematsu K, Kazui S, Yamaguchi T. Mortality and cause of death after hospital discharge in 10,981 patients with ischemic stroke and transient ischemic attack. Cerebrovascular diseases (Basel, Switzerland). 2005; 19(3):171-8. Epub 2005/01/13. doi: 10.1159/000083252 PMID: 15644630.
5. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA: the journal of the American Medical Association. 2002; 287(19):2570-81. Epub 2002/05/22. PMID: 12020339.
6. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocrine reviews. 2001; 22(1):36-52. Epub 2001/02/13. doi: 10.1210/edrv.22.1.0417 PMID: 11159815.
7. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007; 115(10):1285-95. Epub 2007/03/14. doi: 10.1161/circulationaha.106.652859PMID: 17353456.
8. Hollenberg SM, Cinel I. Bench-to-bedside review: nitric oxide in critical illness-update 2008. Critical care (London, England). 2009; 13(4):218. Epub 2009/08/12. doi: 10.1186/cc7706 PMID: 19664175; PubMed Central PMCID: PMC2750127.
9. Henry RM, Ferreira I, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, et al. Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not; The Hoorn Study. Atherosclerosis. 2004; 174(1):49-56. Epub 2004/05/12. doi: 10.1016/j. atherosclerosis.2004.01.002 PMID: 15135250.
10. Gaspari T, Liu H, Welungoda I, Hu Y, Widdop RE, Knudsen LB, et al. A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/-mouse model. Diabetes & vascular disease research: official journal of the International Society of Diabetes and Vascular Disease. 2011; 8(2):117-24. Epub 2011/05/13. doi: 10.1177/1479164111404257 PMID: 21562063.
11. Han L, Yu Y, Sun X, Wang B. Exendin-4 directly improves endothelial dysfunction in isolated aortas from obese rats through the cAMP or AMPK-eNOS pathways. Diabetes research and clinical practice. 2012; 97(3):453-60. Epub 2012/05/09. doi: 10.1016/j.diabres.2012.04.001 PMID: 22560150.
12. Nystrom T, Gutniak MK, Zhang Q, Zhang F, Holst JJ, Ahren B, et al. Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. American journal of physiology Endocrinology and metabolism. 2004; 287(6):E1209-15. Epub 2004/09/09. doi: 10.1152/ ajpendo.00237.2004 PMID: 15353407.
13. Irace C, De Luca S, Shehaj E, Carallo C, Loprete A, Scavelli F, et al. Exenatide improves endothelial function assessed by flow mediated dilation technique in subjects with type 2 diabetes: results from an observational research. Diabetes & vascular disease research: official journal of the International Society of Diabetes and Vascular Disease. 2013; 10(1):72-7. Epub 2012/06/27. doi: 10.1177/1479164112449562 PMID: 22732108.
14. Kelly AS, Bergenstal RM, Gonzalez-Campoy JM, Katz H, Bank AJ. Effects of exenatide vs. metformin on endothelial function in obese patients with pre-diabetes: a randomized trial. Cardiovascular diabetology. 2012; 11:64. Epub 2012/06/12. doi: 10.1186/1475-2840-11-64 PMID: 22681705; PubMed Central PMCID: PMC3434036.
15. Hopkins ND, Cuthbertson DJ, Kemp GJ, Pugh C, Green DJ, Cable NT, et al. Effects of 6 months glucagon-like peptide-1 receptor agonist treatment on endothelial function in type 2 diabetes mellitus patients. Diabetes, obesity & metabolism. 2013; 15(8):770-3. Epub 2013/03/05. doi: 10.1111/dom.12089 PMID: 23451821.
16. Papathanassiou K, Naka KK, Kazakos N, Kanioglou C, Makriyiannis D, Pappas K, et al. Pioglitazone vs glimepiride: Differential effects on vascular endothelial function in patients with type 2 diabetes. Atherosclerosis. 2009; 205(1):221-6. Epub 2009/01/13. doi: 10.1016/j.atherosclerosis.2008.11.027 PMID: 19135671.
17. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. Journal of the American College of Cardiology. 2002; 39(2):257-65. Epub 2002/01/15. PMID: 11788217.
18. Furumoto T, Fujii S, Nishihara K, Yamada S, Komuro K, Goto K, et al. Maladaptive arterial remodeling with systemic hypertension associated with increased concentrations in blood of plasminogen activator inhibitor type-1 (PAI-1). The American journal of cardiology. 2004; 93(8):997-1001. Epub 2004/04/15. doi: 10.1016/j.amjcard.2003.12.053 PMID: 15081442.
19. Tomiyama H, Kohro T, Higashi Y, Takase B, Suzuki T, Ishizu T, et al. A multicenter study design to assess the clinical usefulness of semi-automatic measurement of flow-mediated vasodilatation of the brachial artery. International heart journal. 2012; 53(3):170-5. Epub 2012/07/14. PMID: 22790685.
20. Okamoto T, Sakamaki-Sunaga M, Min S, Miura T, Iwasaki T. Acute effect of brisk walking with graduated compression stockings on vascular endothelial function and oxidative stress. Clinical physiology and functional imaging. 2013; 33(6):455-62. Epub 2013/05/25. doi: 10.1111/cpf.12052 PMID: 23701492.
21. Cesarone MR, Belcaro G, Carratelli M, Cornelli U, De Sanctis MT, Incandela L, et al. A simple test to monitor oxidative stress. International angiology: a journal of the International Union of Angiology. 1999; 18(2):127-30. Epub 1999/07/29. PMID: 10424368.
22. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF Jr, et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation. 2004; 109(5):613-9. Epub 2004/02/11. doi: 10.1161/01.cir.0000112565.60887.1e PMID: 14769683.
23. Iwata M, Miyashita Y, Kumagai H. Seasonal variation of endothelium-dependent flow-mediated vasodilation measured in the same subjects. American journal of cardiovascular disease. 2012; 2(2):111-5.Epub 2012/06/22. PMID: 22720200; PubMed Central PMCID: PMC3371618.
24. Amir O, Alroy S, Schliamser JE, Asmir I, Shiran A, Flugelman MY, et al. Brachial artery endothelial function in residents and fellows working night shifts. The American journal of cardiology. 2004; 93(7): 947-9. Epub 2004/03/31. doi: 10.1016/j.amjcard.2003.12.032 PMID: 15050508.
25. Spieker LE, Hurlimann D, Ruschitzka F, Corti R, Enseleit F, Shaw S, et al. Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation. 2002; 105(24):2817-20. Epub 2002/06/19. PMID: 12070106.
26. Li S, Wu Y, Yu G, Xia Q, Xu Y. Angiotensin II receptor blockers improve peripheral endothelial function: a meta-analysis of randomized controlled trials. PloS one. 2014; 9(3):e90217. Epub 2014/03/07. doi: 10.1371/journal.pone.0090217 PMID: 24595033; PubMed Central PMCID: PMC3940822.
27. Takagi H, Yamamoto H, Iwata K, Goto SN, Umemoto T. Low-density lipoprotein-independent improvement of flow-mediated dilatation with atorvastatin: a meta-analysis and meta-regression of randomized controlled trials. International journal of cardiology. 2012; 158(2):285-9. Epub 2012/05/09. doi: 10. 1016/j.ijcard.2012.04.054 PMID: 22560909.
28. Wascher TC, Schmoelzer I, Wiegratz A, Stuehlinger M, Mueller-Wieland D, Kotzka J, et al. Reduction of postchallenge hyperglycaemia prevents acute endothelial dysfunction in subjects with impaired glucose tolerance. European journal of clinical investigation. 2005; 35(9):551-7. Epub 2005/09/01. doi: 10.1111/j.1365-2362.2005.01550.x PMID: 16128861.
29. Basu A, Charkoudian N, Schrage W, Rizza RA, Basu R, Joyner MJ. Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride. American journal of physiology Endocrinology and metabolism. 2007; 293(5):E1289-95. Epub 2007/08/23. doi: 10.1152/ ajpendo.00373.2007 PMID: 17711996.
30. Koska J, Schwartz EA, Mullin MP, Schwenke DC, Reaven PD. Improvement of postprandial endothelial function after a single dose of exenatide in individuals with impaired glucose tolerance and recentonset type 2 diabetes. Diabetes care. 2010; 33(5):1028-30. Epub 2010/03/05. doi: 10.2337/dc09-1961PMID: 20200309; PubMed Central PMCID: PMC2858168.
31. Song X, Jia H, Jiang Y, Wang L, Zhang Y, Mu Y, et al. Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 Diabetes Mellitus: A meta-analysis. Scientific reports. 2015; 5:10202. Epub 2015/06/27. doi: 10.1038/srep10202 PMID: 26111974; PubMed Central PMCID: PMCPmc4481643.
32. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002; 39(1):10-5. Epub 2002/01/19. PMID: 11799071.
33. Brooks BA, Molyneaux LM, Yue DK. Augmentation of central arterial pressure in Type 2 diabetes. Diabetic medicine: a journal of the British Diabetic Association. 2001; 18(5):374-80. Epub 2001/07/27.PMID: 11472448.
34. Iketani T, Iketani Y, Takazawa K, Yamashina A. The influence of the peripheral reflection wave on left ventricular hypertrophy in patients with essential hypertension. Hypertension research: official journal of the Japanese Society of Hypertension. 2000; 23(5):451-8. Epub 2000/10/04. PMID: 11016799.
35. Pyke C, Knudsen LB. The glucagon-like peptide-1 receptor-or not? Endocrinology. 2013; 154(1):4-8. Epub 2012/12/26. doi: 10.1210/en.2012-2124 PMID: 23267050.
36. Richards P, Parker HE, Adriaenssens AE, Hodgson JM, Cork SC, Trapp S, et al. Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model. Diabetes. 2014; 63(4):1224-33. Epub 2013/12/04. doi: 10.2337/db13-1440 PMID: 24296712; PubMed Central PMCID: PMC4092212.
37. Merani S, Truong W, Emamaullee JA, Toso C, Knudsen LB, Shapiro AM. Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice. Endocrinology. 2008; 149(9):4322-8. Epub 2008/05/31. doi: 10.1210/en.2008-0501 PMID: 18511515.
38. Luo X, Pan L, Nie A, Wang Q, Gu Y, Li F, et al. Liraglutide protects pancreatic beta cells during an early intervention in Gato-Kakizaki rats. Journal of diabetes. 2013; 5(4):421-8. Epub 2013/04/18. doi: 10. 1111/1753-0407.12061 PMID: 23590680.
39. Okuno Y, Komada H, Sakaguchi K, Nakamura T, Hashimoto N, Hirota Y, et al. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes. Metabolism: clinical and experimental. 2013; 62(10):1470-6. Epub 2013/07/09. doi: 10.1016/j.metabol.2013.05.022 PMID: 23831440.
40. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arteriosclerosis, thrombosis, and vascular biology. 2005; 25(1):29-38. Epub 2004/11/13. doi: 10.1161/01.atv. 0000150649.39934.13 PMID: 15539615.
41. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. The Journal of biological chemistry. 2004; 279(41):42351-4. Epub 2004/07/20. doi: 10.1074/jbc.R400019200 PMID: 15258147.
42. Matsushima S, Ide T, Yamato M, Matsusaka H, Hattori F, Ikeuchi M, et al. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation. 2006; 113(14):1779-86. Epub 2006/04/06. doi: 10.1161/circulationaha.105.582239 PMID: 16585391.
43. Jimenez-Feltstrom J, Lundquist I, Salehi A. Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP/PKA pathway. Cell and tissue research. 2005; 319(2):221-30. Epub 2004/11/24. doi: 10.1007/s00441-004-1013-4 PMID: 15558323.
44. Grankvist K, Marklund SL, Taljedal IB. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. The Biochemical journal. 1981; 199(2):393-8. Epub 1981/11/01. PMID: 7041886; PubMed Central PMCID: PMCPmc1163382.